Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Cellnovo. (7/7/17). "Press Release: Cellnovo Successfully Raises €17.5 Million from Healthcare Investors [Not for Distribution in the United States of America, Canada, Australia and Japan]".

Organisations Organisation Cellnovo Group S.A. (Euronext: CLNV)
  Group Cellnovo (Group)
  Organisation 2 INSTITUTIONAL INVESTORS
Products Product Cellnovo Diabetes Management System
  Product 2 investment banking
Index term Index term Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors
Persons Person Baratte, Sophie (Cellnovo 201602 CEO)
  Person 2 Merigeau, Nicolas (NewCap 201502)
     


   
Record changed: 2017-08-24

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px

More documents for Cellnovo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top